Literature DB >> 12447731

Human leukocyte antigen class II and cervical cancer risk: a population-based study.

Margaret M Madeleine1, Babette Brumback, Kara L Cushing-Haugen, Stephen M Schwartz, Janet R Daling, Anajane G Smith, J Lee Nelson, Peggy Porter, Katherine A Shera, James K McDougall, Denise A Galloway.   

Abstract

The critical role of the human leukocyte antigen (HLA) system in presenting peptides to antigen-specific T cell receptors may explain why only some human papillomavirus (HPV)-infected women progress to cervical cancer. HLA class II DRB1 and DQB1 genes were examined in 315 women with invasive squamous cell cervical cancer (SCC) and 381 control subjects. Increased risks of SCC were associated with DRB1*1001, DRB1*1101, and DQB1*0301, and decreased risks were associated with DRB1*0301 and DRB1*13. Of squamous cell tumors, those containing HPV-16 were different from those not containing HPV-16 for 3 alleles: DRB1*0401, DRB1*07, and DQB1*06. Increased risks of SCC were associated with DRB1*0401-DQB1*0301 (odds ratio [OR], 1.7; 95% confidence interval [CI], 1.1-2.7) and DRB1*1101-DQB1*0301 (OR, 2.5; 95% CI, 1.4-4.5), and decreased risks were associated with DRB1*0301-DQB1*02 (OR, 0.7; 95% CI, 0.5-1.0) and DRB1*13-DQB1*06 (OR, 0.6; 95% CI, 0.4-0.9) haplotypes. These results add to the evidence that certain HLA class II alleles or allele combinations, or genes linked to them, make some women more susceptible to SCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12447731     DOI: 10.1086/345285

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: a population-based case-control study.

Authors:  Clara Bodelon; Margaret M Madeleine; Lisa G Johnson; Qin Du; Denise A Galloway; Mari Malkki; Effie W Petersdorf; Stephen M Schwartz
Journal:  Int J Cancer       Date:  2013-08-05       Impact factor: 7.396

2.  Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients.

Authors:  R Reshef; M R Luskin; M Kamoun; S Vardhanabhuti; J E Tomaszewski; E A Stadtmauer; D L Porter; D F Heitjan; De E Tsai
Journal:  Am J Transplant       Date:  2011-03-14       Impact factor: 8.086

3.  Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk.

Authors:  Margaret M Madeleine; Lisa G Johnson; Anajane G Smith; John A Hansen; Brenda B Nisperos; Sue Li; Lue-Ping Zhao; Janet R Daling; Stephen M Schwartz; Denise A Galloway
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

4.  Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma.

Authors:  Yuri Agrawal; Wayne M Koch; Weihong Xiao; William H Westra; Anna L Trivett; David E Symer; Maura L Gillison
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

5.  Multicenter initiative seeking critical genes in respiratory papillomatosis.

Authors:  Farrel J Buchinsky; Craig S Derkay; Suzanne M Leal; Joseph Donfack; Garth D Ehrlich; J Christopher Post
Journal:  Laryngoscope       Date:  2004-02       Impact factor: 3.325

6.  Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions.

Authors:  Thiago Theodoro Martins Prata; Camila Mareti Bonin; Alda Maria Teixeira Ferreira; Cacilda Tezelli Junqueira Padovani; Carlos Eurico dos Santos Fernandes; Ana Paula Machado; Inês Aparecida Tozetti
Journal:  Immunology       Date:  2015-07-01       Impact factor: 7.397

7.  Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants.

Authors:  Jason H Karnes; Lisa Bastarache; Christian M Shaffer; Silvana Gaudieri; Yaomin Xu; Andrew M Glazer; Jonathan D Mosley; Shilin Zhao; Soumya Raychaudhuri; Simon Mallal; Zhan Ye; John G Mayer; Murray H Brilliant; Scott J Hebbring; Dan M Roden; Elizabeth J Phillips; Joshua C Denny
Journal:  Sci Transl Med       Date:  2017-05-10       Impact factor: 17.956

8.  HLA-DRB1 Class II antigen level alleles are associated with persistent HPV infection in Mexican women; a pilot study.

Authors:  Sofía Bernal-Silva; Julio Granados; Clara Gorodezky; Carmen Aláez; Hilario Flores-Aguilar; Ricardo M Cerda-Flores; Geraldina Guerrero-González; Lezmes D Valdez-Chapa; José Morales-Casas; Juan Francisco González-Guerrero; Hugo A Barrera-Saldaña
Journal:  Infect Agent Cancer       Date:  2013-08-30       Impact factor: 2.965

9.  Colorectal cancer biomarkers and the potential role of cancer stem cells.

Authors:  Russell C Langan; John E Mullinax; Manish T Raiji; Trevor Upham; Thomas Summers; Alexander Stojadinovic; Itzhak Avital
Journal:  J Cancer       Date:  2013-03-15       Impact factor: 4.207

10.  The association of the immune response genes to human papillomavirus-related cervical disease in a Brazilian population.

Authors:  Amanda Vansan Marangon; Gláucia Andreia Soares Guelsin; Jeane Eliete Laguila Visentainer; Sueli Donizete Borelli; Maria Angélica Ehara Watanabe; Márcia Edilaine Lopes Consolaro; Katiany Rizzieri Caleffi-Ferracioli; Cristiane Conceição Chagas Rudnick; Ana Maria Sell
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.